During the past decade, Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 11 clinical trials were completed, i.e. on average, 91.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Ferring Pharmaceuticals" with 2 trials sponsored, "Helsinn Healthcare SA" with 2 trials sponsored, "Kartos Therapeutics, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "Pharmacyclics LLC." with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka" are "Prostate Cancer" (3 trials), "Bladder Cancer" (2 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Primary Myelofibrosis (PMF)" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka" are "Drug" (21 trials), "Biological" (2 trials), "Combination Product" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Dexamethasone" (3 trials), "Apaziquone" (2 trials), "Degarelix" (2 trials) and "Enzalutamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka" are 18 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Wojewodzki Szpital Specjalistyczny im. Janusza. Korczaka has several departments that took part in Clinical trials: "Wojewodzki Szpital Specjalistyczny im. J. Korczaka; Oddział Chorób Wewnetrznych/Hematologiczny" - 3 trials